Dr. Meri Nisimova, MD

Dr. Nisimova practices at Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network.

Dr. Nisimova's NPI, 1124063219, was assigned on June 20, 2006. Dr. Nisimova graduated from First Tashkent State Medical Institute in 1979. Dr. Nisimova holds New York license 235257.

Dr. Nisimova's primary practice is Jamaica Hospital Medical Center, at 89th Avenue and Van Wyck Expressway, Jamaica, NY 11418 in Queens County. The practice phone is (718) 262-6000. Dr. Nisimova also practices at Jamaica Hospital Medical Center, 89- Van Wyck Expy, Richmond Hill, NY 11418.

Dr. Nisimova's primary practice is Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network. The medical group on file is Jamaica Hospital Medical Center. Dmand AI also links Dr. Nisimova to 2 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Nisimova's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nisimova practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Nisimova's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Nisimova is licensed in New York.

CMS data shows 172 Medicare services from Dr. Nisimova across 3 procedure codes in 2024, for 79 Medicare patients. Medicare paid $7,240 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Nisimova in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 76% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nisimova's median patient age at 51, with 52% women.

In 2024, Dr. Nisimova wrote 162 Medicare Part D claims for 23 patients. 97% of them were for generic drugs. CMS names the drug for 94 of them, across 6 drugs with 11 or more claims each, at $755 in total drug cost. In 2023, CMS named 643 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Nisimova for performance year 2024, reported as part of a group. Dr. Nisimova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nisimova as offering telehealth.

CMS Open Payments shows 163 general payments to Dr. Nisimova from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $1,275.

Dr. Nisimova graduated from First Tashkent State Medical Institute in 1979.